<DOC>
	<DOCNO>NCT01456546</DOCNO>
	<brief_summary>The aim study investigate genetic variant CYP2C19*17 affect pharmacokinetics proguanil clopidogrel .</brief_summary>
	<brief_title>Impact CYP2C19*17 Pharmacokinetics Proguanil Clopidogrel</brief_title>
	<detailed_description />
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Proguanil</mesh_term>
	<criteria>Healthy volunteer Written consent Age 1865 CYP2C19*1 CYP2C19*17 genotype . Daily medication Alcohol abuse Pregnancy Breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>CYP2C19*17</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
</DOC>